Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC5 | O15392 | 1/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4590763 | 0.99 | BIRC5 (0.46) | BIRC5MCHR1KCNH2MCL1CYP19A1 | |
| SCHEMBL5736518 | 0.88 | KCNH2 (0.47) | MCHR1KCNH2HRH3 | |
| SCHEMBL5736911 | 0.88 | KCNH2 (0.47) | MCHR1KCNH2HRH3 | |
| SCHEMBL5737170 | 0.87 | SLC6A2 (0.44) | KCNH2 | |
| SCHEMBL5735387 | 0.87 | FGFR1 (0.46) | — | |
| SCHEMBL5736908 | 0.86 | KCNH2 (0.48) | MCHR1KCNH2HRH3 | |
| SCHEMBL5735248 | 0.82 | KCNH2 (0.49) | MCHR1KCNH2HRH3 | |
| SCHEMBL5736008 | 0.78 | BIRC5 (0.40) | BIRC5KCNH2CYP19A1 | |
| SCHEMBL4591158 | 0.78 | HRH3 (0.46) | MCHR1KCNH2HRH3 | |
| SCHEMBL6561694 | 0.77 | FGFR1 (0.47) | BIRC5MCHR1KCNH2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008107322-A1 | INDOLE, BENZIMIDAZOLE OR BENZOTRIAZOLE DERIVATIVES INCLUDING A PIPERIDINE OR PIPERAZINE CORE AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS | CEREP (FR) | 2008-09-12 | — | — | WO | disclosed |